New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiodarone hydrochloride 50 mg/ml;   - solution for injection - 150mg/3ml - active: amiodarone hydrochloride 50 mg/ml   excipient: benzyl alcohol polysorbate 80 water for injection - tachyarrhythmias associated with wolff-parkinson-white syndrome. all types of tachyarrhythmias including; supraventricular, nodal and ventricular tachycardias, atrial flutter and fibrillation; ventricular fibrillation; when other agents cannot be used. the injection is to be used when a rapid response is required.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - fluconazole 150mg;   - capsule - 150 mg - active: fluconazole 150mg   excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - fluconazole 50mg;   - capsule - 50 mg - active: fluconazole 50mg   excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch

New Zealand - English - Medsafe (Medicines Safety Authority)

jntl consumer health (new zealand) limited - fluconazole 150mg;   - capsule - 150 mg - active: fluconazole 150mg   excipient: colloidal silicon dioxide gelatin lactose monohydrate magnesium stearate maize starch patent blue v tekprint black sw-9008 titanium dioxide - vaginal candidiasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenytoin 50mg; phenytoin 50mg; phenytoin 50mg - chewable tablet - 50 mg - active: phenytoin 50mg excipient: magnesium stearate purified talc quinoline yellow saccharin sodium spearmint flavour natural 11584 sucrose sunset yellow fcf wheat starch active: phenytoin 50mg excipient: spearmint flavour natural 11584 magnesium stearate maize starch purified talc quinoline yellow saccharin sodium sucrose sunset yellow fcf active: phenytoin 50mg excipient: confectioner's sugar magnesium stearate purified talc quinoline yellow saccharin sodium spearmint flavour natural 11584 sunset yellow fcf - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - fluconazole 150mg; fluconazole 150mg - capsule - 150 mg - active: fluconazole 150mg excipient: gelatin hydrated silica lactose monohydrate magnesium stearate pregelatinised maize starch sodium laurilsulfate tekprint black sw-9008 tekprint black sw-9009 titanium dioxide active: fluconazole 150mg excipient: gelatin hydrated silica lactose monohydrate magnesium stearate maize starch sodium laurilsulfate tekprint black sw-9008 tekprint black sw-9009 titanium dioxide - fluconazole is indicated for the treatment of vaginal candidiasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 50mg;   - soft gelatin capsule - 50 mg - active: ciclosporin 50mg   excipient: corn oil dl-alpha tocopherol ethanol gelatin glycerol polyethylene glycol hydrogenated castor oil propylene glycol   titanium dioxide - solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - zidovudine 250mg - capsule - 250 mg - active: zidovudine 250mg excipient: gelatin ink magnesium stearate maize starch microcrystalline cellulose sodium starch glycolate - retrovir oral formulations are indicated in combination with other anti-retroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - disopyramide 150mg (as base) - capsule - 150 mg - active: disopyramide 150mg (as base) excipient: gelatin magnesium stearate maize starch purified talc starch titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 50 mg/ml - solution for infusion - 250 mg/5ml - active: ciclosporin 50 mg/ml excipient: ethanol polyoxyl 35 castor oil - solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).